Literature DB >> 21428987

rRNA-based profiling of bacteria in the axilla of healthy males suggests right-left asymmetry in bacterial activity.

Markus Egert1, Inke Schmidt, Heide-Marie Höhne, Tim Lachnit, Ruth Anne Schmitz, Roland Breves.   

Abstract

The activity of the human armpit microbiota triggers the formation of body odor. We used differential 16S rRNA gene (rDNA)- and rRNA-based terminal-restriction fragment length polymorphism fingerprinting in combination with cloning and sequencing to identify active members of the human armpit microbiota. DNA and RNA were isolated from skin scrub samples taken from both armpits of 10 preconditioned, healthy males. The fingerprint profiles indicated pronounced similarities between the armpit microbiota in the right and the left axillae of an individual test person, but larger differences between the axilla microbiota of different individuals. Using 16S rDNA and rRNA sequence data, the majority of peaks in the armpit profiles were assigned to bacteria affiliated with well-known genera of skin bacteria. The relative abundances of all groups were similar among the rDNA and rRNA samples, suggesting that all groups of armpit bacteria were active. Surprisingly, the relative abundance of sequences affiliated with Peptoniphilus sp. was by far and with statistical significance the highest in the rRNA samples of the right armpits. Thus, bacteria affiliated with Peptoniphilus sp. might have been particularly active in the right axillae of the test persons, possibly owing to the handedness of the test persons, which might cause different environmental conditions in the right axillae.
© 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21428987     DOI: 10.1111/j.1574-6941.2011.01097.x

Source DB:  PubMed          Journal:  FEMS Microbiol Ecol        ISSN: 0168-6496            Impact factor:   4.194


  7 in total

1.  Gut microbial RNA and DNA analysis predicts hospitalizations in cirrhosis.

Authors:  Jasmohan S Bajaj; Leroy R Thacker; Andrew Fagan; Melanie B White; Edith A Gavis; Phillip B Hylemon; Robert Brown; Chathur Acharya; Douglas M Heuman; Michael Fuchs; Swati Dalmet; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  JCI Insight       Date:  2018-03-08

2.  Evaluating rRNA as an indicator of microbial activity in environmental communities: limitations and uses.

Authors:  Steven J Blazewicz; Romain L Barnard; Rebecca A Daly; Mary K Firestone
Journal:  ISME J       Date:  2013-07-04       Impact factor: 10.302

3.  Characterization of Staphylococcus and Corynebacterium clusters in the human axillary region.

Authors:  Chris Callewaert; Frederiek-Maarten Kerckhof; Michael S Granitsiotis; Mireille Van Gele; Tom Van de Wiele; Nico Boon
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

4.  Mapping axillary microbiota responsible for body odours using a culture-independent approach.

Authors:  Myriam Troccaz; Nadia Gaïa; Sabine Beccucci; Jacques Schrenzel; Isabelle Cayeux; Christian Starkenmann; Vladimir Lazarevic
Journal:  Microbiome       Date:  2015-01-24       Impact factor: 14.650

5.  The effect of habitual and experimental antiperspirant and deodorant product use on the armpit microbiome.

Authors:  Julie Urban; Daniel J Fergus; Amy M Savage; Megan Ehlers; Holly L Menninger; Robert R Dunn; Julie E Horvath
Journal:  PeerJ       Date:  2016-02-02       Impact factor: 2.984

6.  The molecular basis of thioalcohol production in human body odour.

Authors:  Michelle Rudden; Reyme Herman; Matthew Rose; Daniel Bawdon; Diana S Cox; Eleanor Dodson; Matthew T G Holden; Anthony J Wilkinson; A Gordon James; Gavin H Thomas
Journal:  Sci Rep       Date:  2020-07-27       Impact factor: 4.379

7.  Structural basis of malodour precursor transport in the human axilla.

Authors:  Gurdeep S Minhas; Daniel Bawdon; Reyme Herman; Michelle Rudden; Andrew P Stone; A Gordon James; Gavin H Thomas; Simon Newstead
Journal:  Elife       Date:  2018-07-03       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.